Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 15;111(19):1479-1486.
doi: 10.1002/bdr2.1563. Epub 2019 Aug 8.

Oseltamivir exposure in pregnancy and the risk of specific birth defects

Carla M Van Bennekom  1 , Stephen M Kerr  1 , Allen A Mitchell  1
Affiliations

Oseltamivir exposure in pregnancy and the risk of specific birth defects

Carla M Van Bennekom et al. Birth Defects Res. .

Abstract

Background: Influenza during pregnancy contributes to maternal morbidity and mortality. Neuraminidase inhibitors, including oseltamivir, are recommended for treating women with influenza during pregnancy.

Methods: Data from the Slone Birth Defects Study from 2009 to 2015 were used to investigate associations between oseltamivir and specific birth defects. We classified exposures according to timing in pregnancy and examined 52 and 16 defects with early and potential late pregnancy etiology, respectively; we calculated crude odds ratios (ORs) and 95% confidence intervals (CIs) for defects with three or more exposures.

Results: Among 8,379 cases and 4,190 nonmalformed controls, we identified 79 and 42 oseltamivir exposures, respectively. The majority of defects had no exposures. ORs were elevated for several defects, but the CI excluded the null only for intestinal malrotation (OR: 10.7 [1.8, 45.2]; three exposures).

Conclusions: Largely null findings for specific defects are reassuring. The association with intestinal malrotation, while unstable, warrants further investigation.

Keywords: birth defects; epidemiology; influenza; oseltamivir; pregnancy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

REFERENCES

    1. Ács, N., Bánhidy, F., Puhó, E., & Czeizel, A. E. (2005). Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Research (Part A), 73(12), 989-996. https://doi.org/10.1002/bdra.20195
    1. American College of Obstetricians and Gynecologists (2018). Influenza vaccination during pregnancy: ACOG Committee Opinion No. 732. Obstetrics and Gynecology, 131(4), e109-e114. https://doi.org/10.1097/aog.0000000000002588
    1. American College of Obstetricians and Gynecologists (2018). Assessment and treatment of pregnant women with suspected or confirmed influenza: ACOG Committee Opinion No. 753. Obstetrics & Gynecology, 132(4), e169-e173. https://doi.org/10.1097/aog.0000000000002872
    1. CDC seasonal flu vaccine effectiveness studies. (2019). Retrieved from https://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm
    1. Chambers, C. D., Johnson, D., Xu, R., Luo, Y., & Jones, K. L. (2019). Oseltamivir Use in Pregnancy: Risk of Birth Defects, Preterm Delivery, and Small for Gestational Age Infants. Birth Defects Research. https://doi.org/10.1002/bdr2.1566.

Publication types

LinkOut - more resources